Cases & Deals

Invirsa develops global patent portfolio directed to INV-102

Clients Invirsa, Inc.

Jones Day represents Invirsa, Inc. in the establishment of a global patent portfolio related to INV-102, a small molecule immune response modulator.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.